Sign In
19 Oct 2012 16:37
ļ»æ
For immediate release | 19 October 2012 |
Ā
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Ā
Share Options
Ā
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that on 19 October 2012 it awarded the following options over ordinary shares of the Company to certain Directors.
Ā
Name | Position | Number of share options awarded | Exercise price per share | Date of vesting | Percentage of issued ordinary share capital |
Tony Booley | Executive Director | 140,000 | 29.25p | 19 October 2015 | 0.06% |
Peter Butterfield Ā | Executive Director | 140,000 | 29.25p | 19 October 2015 | 0.06% |
Richard Wright | Finance Director | 140,000 | 29.25p | 19 October 2015 | 0.06% |
Ā
Ā
For further information:
Ā
Alliance Pharma plc | + 44 (0) 1249 466966 |
John Dawson, Chief Executive | |
Richard Wright, Finance Director | |
www.alliancepharma.co.uk | |
Buchanan Communications | + 44 (0) 20 7466 5000 |
Mark Court / Fiona Henson / Sophie Cowles | |
Numis Securities Limited | + 44 (0) 20 7260 1000 |
Nominated Adviser: Michael Meade / Oliver Cardigan | |
Corporate Broking: David Poutney |
Ā
Notes to editors:
Ā
About Alliance
Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and, following the Cambridge Laboratories acquisition, owns or licenses the rights to more than 50 pharmaceutical products and continues to explore opportunities to expand the range.
Ā
Alliance's products are prescribed in the treatment of a wide range of conditions and include products used in the treatment of dermatological conditions, in oncology, in childbirth, in the prevention of heart disease, in Parkinson's disease, in nutrition and in nasal infections. Alliance's sales are mainly prescription driven. Its products are distributed to hospitals directly and to pharmaceutical wholesalers, which service both hospital and retail pharmacies with their prescription requirements.
Ā
Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.
Follow the stocks
